A correction has been made to the Abstract: “Methods: In this multicenter, double-blind, placebo-controlled, three-arm trial, 390 healthy toddlers were randomized (1:1:1) to receive (1) synbiotic (2′-FL 1.0 g/day + B. infantis R0033 1.5 × 109 CFU + B. bifidum R0071 1.5 × 109 CFU);”
A correction has been made to the Section 2, Section 2.4, paragraph one:
“All eligible children were randomly assigned to the HPG, IG or CG. The children in HPG received a daily supplement of 1.5 billion CFU each of B. infantis R0033 and B. bifidum R0071 and 1.0 g of 2′-FL (Production No: 87-BCP-20027).”
A correction has been made to the Section 5, paragraph one:
“Lastly, administering a single dose of 1.5 billion CFU/day each of B. infantis R0033 and B. bifidum R0071 limited our ability to investigate the optimal dose–response relationship of these two strains in preventing respiratory, gastrointestinal, and allergic diseases.”
The original version of this article has been updated.
Footnotes
Edited and reviewed by: Christophe Lacroix, ETH Zürich, Switzerland
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.